{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:58Z","timestamp":1786979938600,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370151"],"award-info":[{"award-number":["82370151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06821-8","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T06:39:23Z","timestamp":1769668763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["TP53 mutation predict poor prognosis in diffuse large B-cell lymphoma: a single-center study"],"prefix":"10.1007","volume":"105","author":[{"given":"Haiyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingnong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaixiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanzhuo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"6821_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD et al (2020) A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell 37:551-568.e14. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.015","journal-title":"Cancer Cell"},{"issue":"5","key":"6821_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ et al (2018) Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 24(5):679\u2013690. https:\/\/doi.org\/10.1038\/s41591-018-0016-8","journal-title":"Nat Med"},{"key":"6821_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.critrevonc.2015.08.006","volume":"97","author":"TX Lu","year":"2016","unstructured":"Lu TX, Young KH, Xu W et al (2016) TP53 dysfunction in diffuse large B-cell lymphoma. Crit Rev Oncol Hematol 97:47\u201355. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.08.006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"6821_CR4","doi-asserted-by":"publisher","first-page":"14814","DOI":"10.1038\/s41598-018-33230-3","volume":"4","author":"P Peroja","year":"2018","unstructured":"Peroja P, Pedersen M, Mantere T et al (2018) Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP. Sci Rep 4(1):14814. https:\/\/doi.org\/10.1038\/s41598-018-33230-3","journal-title":"Sci Rep"},{"issue":"2","key":"6821_CR5","first-page":"107","volume":"14","author":"M Osada","year":"1999","unstructured":"Osada M, Ishioka C, Ichinohasama R et al (1999) Influence of p53 mutation on pathological grade, but not prognosis of non-Hodgkin\u2019s lymphoma. Anticancer Drug Des 14(2):107\u201314","journal-title":"Anticancer Drug Des"},{"issue":"15","key":"6821_CR6","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1182\/blood.v99.4.1136","volume":"99","author":"SL Barrans","year":"2002","unstructured":"Barrans SL, Carter I, Owen RG et al (2002) Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood 99(15):1136\u20131143. https:\/\/doi.org\/10.1182\/blood.v99.4.1136","journal-title":"Blood"},{"key":"6821_CR7","doi-asserted-by":"publisher","first-page":"1550207","DOI":"10.3389\/fonc.2025.1550207","volume":"15","author":"Y Jin","year":"2025","unstructured":"Jin Y, Wang Y, Wang L et al (2025) TP53 mutation and immunohistochemical p53 expression characteristics in diffuse large B-cell lymphoma. Front Oncol 15:1550207. https:\/\/doi.org\/10.3389\/fonc.2025.1550207","journal-title":"Front Oncol"},{"issue":"12","key":"6821_CR8","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1007\/s00277-023-05420-1","volume":"102","author":"OAEH Ebid","year":"2023","unstructured":"Ebid OAEH, Ezz El Arab LR, Saad AS et al (2023) Prognostic impact of MYD88 and TP53 mutations in diffuse large B cell lymphoma. Ann Hematol 102(12):3477\u20133488. https:\/\/doi.org\/10.1007\/s00277-023-05420-1","journal-title":"Ann Hematol"},{"issue":"1","key":"6821_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41408-024-01153-0","volume":"14","author":"S Mato","year":"2024","unstructured":"Mato S, Castrej\u00f3n-de-Anta N, Colmenero A et al (2024) MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly burkitt lymphoma. Blood Cancer J 14(1):171. https:\/\/doi.org\/10.1038\/s41408-024-01153-0","journal-title":"Blood Cancer J"},{"issue":"1","key":"6821_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12964-024-01765-w","volume":"22","author":"KX Du","year":"2024","unstructured":"Du KX, Wu YF, Hua W et al (2024) Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms. Cell Commun Signal 22(1):401. https:\/\/doi.org\/10.1186\/s12964-024-01765-w","journal-title":"Cell Commun Signal"},{"issue":"6","key":"6821_CR11","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3109\/10428194.2014.970550","volume":"56","author":"I Fiskvik","year":"2015","unstructured":"Fiskvik I, Beiske K, Delabie J et al (2015) Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma. Leuk Lymphoma 56(6):1742\u20131749. https:\/\/doi.org\/10.3109\/10428194.2014.970550","journal-title":"Leuk Lymphoma"},{"issue":"19","key":"6821_CR12","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1182\/blood-2012-05-433334","volume":"120","author":"ZY Xu-Monette","year":"2012","unstructured":"Xu-Monette ZY, Wu L, Visco C et al (2012) Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL rituximab-CHOP consortium program study. Blood 120(19):3986\u20133996. https:\/\/doi.org\/10.1182\/blood-2012-05-433334","journal-title":"Blood"},{"issue":"2","key":"6821_CR13","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/curroncol30020102","volume":"30","author":"JCA Moreno","year":"2023","unstructured":"Moreno JCA, Bahmad HF, Aljamal AA et al (2023) Prognostic significance of p53 and p63 in diffuse large B-cell lymphoma: a single-institution experience. Curr Oncol 30(2):1314\u20131331. https:\/\/doi.org\/10.3390\/curroncol30020102","journal-title":"Curr Oncol"},{"issue":"2","key":"6821_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/path.2744","volume":"222","author":"M K\u00f6bel","year":"2010","unstructured":"K\u00f6bel M, Reuss A, du Bois A et al (2010) The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas. J Pathol 222(2):191\u2013198. https:\/\/doi.org\/10.1002\/path.2744","journal-title":"J Pathol"},{"issue":"4","key":"6821_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cjp2.53","volume":"2","author":"M K\u00f6bel","year":"2016","unstructured":"K\u00f6bel M, Piskorz AM, Lee S et al (2016) Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. J Pathol: Clin Res 2(4):247\u2013258. https:\/\/doi.org\/10.1002\/cjp2.53","journal-title":"J Pathol: Clin Res"},{"issue":"10","key":"6821_CR16","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41379-022-01102-x","volume":"35","author":"L Vermij","year":"2022","unstructured":"Vermij L, L\u00e9on-Castillo A, Singh N et al (2022) p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial. Mod Pathol 35(10):1475\u20131483. https:\/\/doi.org\/10.1038\/s41379-022-01102-x","journal-title":"Mod Pathol"},{"issue":"20","key":"6821_CR17","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"27","key":"6821_CR18","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L et al (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32(27):3048\u20133058. https:\/\/doi.org\/10.1200\/JCO.2013.53.5229","journal-title":"J Clin Oncol"},{"issue":"10","key":"6821_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nature15251","volume":"525","author":"J Zhu","year":"2015","unstructured":"Zhu J, Sammons MA, Donahue G et al (2015) Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. Nature 525(10):206\u2013211. https:\/\/doi.org\/10.1038\/nature15251","journal-title":"Nature"},{"issue":"6","key":"6821_CR20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2004.11.006","volume":"119","author":"GA Lang","year":"2004","unstructured":"Lang GA, Iwakuma T, Suh YA et al (2004) Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119(6):861\u201372. https:\/\/doi.org\/10.1016\/j.cell.2004.11.006","journal-title":"Cell"},{"issue":"7","key":"6821_CR21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/s41379-021-00745-6","volume":"34","author":"TN Aung","year":"2021","unstructured":"Aung TN, Acs B, Warrell J et al (2021) A new tool for technical standardization of the Ki67 immunohistochemical assay. Mod Pathol 34(7):1261\u20131270. https:\/\/doi.org\/10.1038\/s41379-021-00745-6","journal-title":"Mod Pathol"},{"issue":"1","key":"6821_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"1","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 1(1):275\u2013282. https:\/\/doi.org\/10.1182\/blood-2003-05-1545","journal-title":"Blood"},{"issue":"21","key":"6821_CR23","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252\u20137259. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0713","journal-title":"Clin Cancer Res"},{"key":"6821_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143560","volume":"10","author":"Y Lu","year":"2023","unstructured":"Lu Y, Wu M, Xu Y et al (2023) The development of p53-targeted therapies for human cancers. Cancers (Basel) 10:3560. https:\/\/doi.org\/10.3390\/cancers15143560","journal-title":"Cancers (Basel)"},{"issue":"5","key":"6821_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41418-022-00962-9","volume":"29","author":"Z Wang","year":"2022","unstructured":"Wang Z, Strasser A, Kelly GL (2022) Should mutant TP53 be targeted for cancer therapy? Cell Death Differ 29(5):911\u2013920. https:\/\/doi.org\/10.1038\/s41418-022-00962-9","journal-title":"Cell Death Differ"},{"issue":"20","key":"6821_CR26","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood.2019003535","volume":"135","author":"SE Lacy","year":"2020","unstructured":"Lacy SE, Barrans SL, Beer PA et al (2020) Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a haematological malignancy research network report. Blood 135(20):1759\u20131771. https:\/\/doi.org\/10.1182\/blood.2019003535","journal-title":"Blood"},{"issue":"8","key":"6821_CR27","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2008-01-129783","volume":"15","author":"KH Young","year":"2008","unstructured":"Young KH, Leroy K, M\u00f8ller MB et al (2008) Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood 15(8):3088\u20133098. https:\/\/doi.org\/10.1182\/blood-2008-01-129783","journal-title":"Blood"},{"issue":"1","key":"6821_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1182\/asheducation-2013.1.511","volume":"2013","author":"Y Saunthararajah","year":"2013","unstructured":"Saunthararajah Y (2013) Key clinical observations after 5-azacytidine and decitabine treatment of myelodysplastic syndromes suggest practical solutions for better outcomes. Hematol Am Soc Hematol Educ Program 2013(1):511\u2013521. https:\/\/doi.org\/10.1182\/asheducation-2013.1.511","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"6821_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.leukres.2008.06.022","volume":"33","author":"N Zainuddin","year":"2009","unstructured":"Zainuddin N, Berglund M, Wanders A et al (2009) TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype. Leuk Res 33(1):60\u201366. https:\/\/doi.org\/10.1016\/j.leukres.2008.06.022","journal-title":"Leuk Res"},{"issue":"1","key":"6821_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01358-y","volume":"8","author":"R Shen","year":"2023","unstructured":"Shen R, Fu D, Dong L et al (2023) Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma. Signal Transduct Target Ther 8(1):145. https:\/\/doi.org\/10.1038\/s41392-023-01358-y","journal-title":"Signal Transduct Target Ther"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06821-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06821-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06821-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:03:49Z","timestamp":1771398229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06821-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["6821"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06821-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7797367\/v1","asserted-by":"object"}]},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang University School of Medicin. All research was performed in accordance with the Declaration of Helsinki. Due to the retrospective design and the use of fully anonymized clinical and pathological data, the requirement for individual written informed consent was waived by the aforementioned ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"66"}}